This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capac...
Northern RNA Inc.
7 enregistrements totalisant 33,625,700.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Innovation, Sciences et Développement économique Canada | $21,037,700 | 2 enregistrements |
| Conseil national de recherches Canada | $7,588,000 | 4 enregistrements |
| Développement économique Canada pour les Prairies | $5,000,000 | 1 enregistrement |
Enregistrements
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and delivery vehicles such as lipid nanoparticles which have been demonstrated to be import...
Establish oligonucleotide manufacturing, and self-amplifying RNA (saRNA) manufacturing capabilities.
Establish contract manufacturing facility for vaccines and lipids in Western Canada
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreak...
Northern RNA is developing GMP manufacturing of mRNA and DNA based vaccines at our Calgary, Alberta based facility. GMP certification requires the development and documentation of all processes relat...
The firm is aiming to develop lab methodologies that are applicable for oligonucleotide separation and its purification. These methods will be applicable depending on the length of the oligonucleotide...